Documents

A list of downloadable documents created during development.

Assessment report sent for information

Protocol

Response to comments on scope and matrix

Equality impact assessment form

Final matrix

Final scope

Diabetes (type 2) - canagliflozin, dapagliflozin and empagliflozin (monotherapy): draft scope (post-referral)

Diabetes (type 2) - canagliflozin, dapagliflozin and empagliflozin (monotherapy): provisional matrix (post-referral)